{"id":52604,"date":"2023-01-05T21:03:24","date_gmt":"2023-01-05T20:03:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/"},"modified":"2023-01-05T21:03:24","modified_gmt":"2023-01-05T20:03:24","slug":"joimax-announces-executive-appointments-among-record-breaking-sales-for-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/","title":{"rendered":"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022"},"content":{"rendered":"
\n

KARLSRUHE, Germany–(BUSINESS WIRE)–#endoscopic<\/a>—joimax\u00ae<\/a>, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022.\n<\/p>\n

<\/a><\/p>\n

\nRies took on the newly created role of Executive Vice President, Business Development and Operations at joimax\u00ae. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax\u00ae continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax\u00ae, Ries built out the United States and Latin American markets.\n<\/p>\n

\nTroncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax\u00ae Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax\u00ae in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine.\n<\/p>\n

\nContributing to the global organization\u2019s continuous strong sales growth was the launch of a new surgical access system, \u201cTessys\u00ae Trans SAP\u201d and the global expansion of the ESPINEA\u00ae Education Academy.\n<\/p>\n

\n\u201cI am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,\u201d stated joimax\u00ae Founder and CEO Wolfgang Ries. \u201cWith Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.\u201d\n<\/p>\n

\nAbout <\/b>joimax\u00ae<\/a>\n<\/p>\n

\nFounded in Karlsruhe, Germany, in 2001, joimax\u00ae<\/sup> is the leading developer and marketer of complete systems for full-endoscopic and minimally invasive spinal surgery. With the Endoscopic Surgical Systems TESSYS\u00ae<\/sup> (transforaminal), iLESSYS\u00ae<\/sup> (interlaminar) and CESSYS\u00ae<\/sup> (cervical) for decompression procedures, MultiZYTE\u00ae<\/sup> for facet and sacroiliac joint pain treatment, EndoLIF\u00ae<\/sup> and Percusys\u00ae<\/sup> for minimally-invasive endoscopically assisted stabilizations, established systems are provided, addressing a whole range of indications. All methods are supported by the latest generation electronical devices in the all new NAVENTO\u00ae<\/sup> navigated endoscopic tower. In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax\u00ae<\/sup> technologies to operate through small incisions under local or full anesthesia, via tissue and muscle-sparing corridors and through natural openings in the spinal canal, e.g. the intervertebral foramen, the so-called \u201cKambin triangle\u201d.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPress Contact Germany
\n
joimax\u00ae GmbH
\n
Susanne Schmidinger
\n
susanne.schmidinger@joimax.com<\/a>
+49-721-25514-0\n<\/p>\n

\nPress Contact USA
\n
joimax\u00ae, Inc.
\n
Emma Gartner
\n
emma.gartner@joimaxusa.com<\/a>
+1-949-859-3472\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

KARLSRUHE, Germany–(BUSINESS WIRE)–#endoscopic—joimax\u00ae, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022. Ries took on the newly … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52604","6":"format-standard","7":"category-industry"},"yoast_head":"\njoimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"KARLSRUHE, Germany–(BUSINESS WIRE)–#endoscopic—joimax\u00ae, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022. Ries took on the newly ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T20:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230105005905\/en\/1678495\/21\/Logo2023.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022\",\"datePublished\":\"2023-01-05T20:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005905\\\/en\\\/1678495\\\/21\\\/Logo2023.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/\",\"name\":\"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005905\\\/en\\\/1678495\\\/21\\\/Logo2023.jpg\",\"datePublished\":\"2023-01-05T20:03:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005905\\\/en\\\/1678495\\\/21\\\/Logo2023.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005905\\\/en\\\/1678495\\\/21\\\/Logo2023.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/","og_locale":"en_US","og_type":"article","og_title":"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022 - Pharma Trend","og_description":"KARLSRUHE, Germany–(BUSINESS WIRE)–#endoscopic—joimax\u00ae, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022. Ries took on the newly ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-05T20:03:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230105005905\/en\/1678495\/21\/Logo2023.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022","datePublished":"2023-01-05T20:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/"},"wordCount":444,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005905\/en\/1678495\/21\/Logo2023.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/","url":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/","name":"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005905\/en\/1678495\/21\/Logo2023.jpg","datePublished":"2023-01-05T20:03:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230105005905\/en\/1678495\/21\/Logo2023.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230105005905\/en\/1678495\/21\/Logo2023.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/joimax-announces-executive-appointments-among-record-breaking-sales-for-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"joimax\u00ae Announces Executive Appointments Among Record-Breaking Sales for 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52604"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52604\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}